Corrigendum: MiR-148b suppresses cell proliferation and invasion in hepatocellular carcinoma by targeting WNT1/β-catenin pathway (Scientific Reports (2015) 5 (8087) DOI: 10.1038/srep08087);MiR-148b suppresses cell proliferation and invasion in hepatocellular carcinoma by targeting WNT1/β-catenin pathway

Scientific Reports

Volumn 5, Issue , 2015, Pages

  Zhang, Jun Gang ^a,b   Shi, Ying ^b   Hong, De Fei ^b   Song, Mengqi ^a   Huang, Dongsheng ^b   Wang, Chun You ^a   Zhao, Gang ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b ZHEJIANG PROVINCIAL PEOPLE'S HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

3' UNTRANSLATED REGION; MICRORNA; MIRN148 MICRORNA, HUMAN; WNT1 PROTEIN;

3' UNTRANSLATED REGION; AGED; ANIMAL; APOPTOSIS; BAGG ALBINO MOUSE; CELL CYCLE CHECKPOINT; CELL PROLIFERATION; FEMALE; GENE EXPRESSION REGULATION; GENETIC TRANSFECTION; GENETICS; HEPG2 CELL LINE; HUMAN; LIVER; LIVER CELL CARCINOMA; LIVER TUMOR; MALE; METABOLISM; MIDDLE AGED; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; NUDE MOUSE; PATHOLOGY; SURVIVAL; TUMOR INVASION; WESTERN BLOTTING; WNT SIGNALING PATHWAY;

3' UNTRANSLATED REGIONS; AGED; ANIMALS; APOPTOSIS; BASE SEQUENCE; BLOTTING, WESTERN; CARCINOMA, HEPATOCELLULAR; CELL CYCLE CHECKPOINTS; CELL PROLIFERATION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HEP G2 CELLS; HUMANS; LIVER; LIVER NEOPLASMS; MALE; MICE, INBRED BALB C; MICE, NUDE; MICRORNAS; MIDDLE AGED; MOLECULAR SEQUENCE DATA; NEOPLASM INVASIVENESS; SURVIVAL ANALYSIS; TRANSFECTION; WNT SIGNALING PATHWAY; WNT1 PROTEIN;

EID: 84927665850     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep46886     Document Type: Erratum

References (46)

1. Parkin, D. M., Bray, F., Ferlay, J., Pisani, P. Global cancer statistics, 2002. CA Cancer J Clin 55, 74-108 (2005).
2. Llovet, J.M., Bruix, J. Molecular targeted therapies in hepatocellular carcinoma. Hepatology 48, 1312-1327 (2008).
3. Poon, R. T., Fan, S. T. Hepatectomy for hepatocellular carcinoma: patient selection and postoperative outcome. Liver Transpl 10, S39-45 (2004).
4. Chu, R. et al. miRNAs affect the development of hepatocellular carcinoma via dysregulation of their biogenesis and expression. Cell Commun Signal 12, 45, doi:s12964-014-0045-y (2014).
5. Hoshida, Y. et al. Integrative transcriptome analysis reveals common molecular subclasses of human hepatocellular carcinoma. Cancer Res 69, 7385-7392 (2009).
6. Iwakawa, H. O., Tomari, Y. Molecular insights into microRNA-mediated translational repression in plants. Mol Cell 52, 591-601 (2013).
7. Engels, B. M.& Hutvagner, G. Principles and effects of microRNA-mediated posttranscriptional gene regulation. Oncogene 25, 6163-6169 (2006).
8. Bjorner, S. et al. Epithelial and Stromal MicroRNA Signatures of Columnar Cell Hyperplasia Linking Let-7c to Precancerous and Cancerous Breast Cancer Cell Proliferation. PLoS One 9, e105099 (2014).
9. Gibb, E. A., Brown, C. J., Lam, W. L. The functional role of long non-coding RNA in human carcinomas. Mol Cancer 10, 38 (2011).
10. Budhu, A. et al. Identification of metastasis-related microRNAs in hepatocellular carcinoma. Hepatology 47, 897-907 (2008).
11. Hunt, S., Jones, A. V., Hinsley, E. E., Whawell, S. A., Lambert, D. W. MicroRNA-124 suppresses oral squamous cell carcinoma motility by targeting ITGB1. FEBS Lett 585, 187-192 (2011).
12. Iorio, M. V., Croce, C. M. microRNA involvement in human cancer. Carcinogenesis 33, 1126-1133 (2012).
13. Gramantieri, L. et al. Cyclin G1 is a target of miR-122a, a microRNA frequently down-regulated in human hepatocellular carcinoma. Cancer Res 67, 6092-6099 (2007).
14. Yang, Y. M. et al. Galpha gep oncogene deregulation of p53-responsive microRNAs promotes epithelial-mesenchymal transition of hepatocellular carcinoma. Oncogene 0, doi:10.1038/onc.2014.218 onc2014218 (2014).
15. Zhu, K. et al. MiR-302c inhibits tumor growth of hepatocellular carcinoma by suppressing the endothelial-mesenchymal transition of endothelial cells. Sci Rep 4, 5524, doi:10.1038/srep05524 srep05524 (2014).
16. Song, Y. et al. MicroRNA-148b suppresses cell growth by targeting cholecystokinin-2 receptor in colorectal cancer. Int J Cancer 131, 1042-1051 (2012).
17. Song, Y. X. et al. MicroRNA-148b is frequently down-regulated in gastric cancer and acts as a tumor suppressor by inhibiting cell proliferation. Mol Cancer 10, 1 (2011).
18. Cimino, D. et al.miR148b is amajor coordinator of breast cancer progression in a relapse-associated microRNA signature by targeting ITGA5, ROCK1, PIK3CA, NRAS, and CSF1. FASEB J 27, 1223-1235 (2013).
19. Bloomston, M. et al. MicroRNA expression patterns to differentiate pancreatic adenocarcinoma from normal pancreas and chronic pancreatitis. JAMA 297, 1901-1908 (2007).
20. Chang, H. et al. Increased expression of miR-148b in ovarian carcinoma and its clinical significance. Mol Med Rep 5, 1277-1280 (2012).
21. Zhang, Z., Zheng, W., Hai, J. MicroRNA-148b expression is decreased in hepatocellular carcinoma and associated with prognosis. Med Oncol 31, 984 (2014).
22. Wieczorek, M. et al. Silencing of Wnt-1 by siRNA induces apoptosis of MCF-7 human breast cancer cells. Cancer Biol Ther 7, 268-274 (2008).
23. Wang, J. M. et al. Inhibition of Cancer Cell Migration and Invasion through Suppressing the Wnt1-mediating Signal Pathway by G-quadruplex Structure Stabilizers. J Biol Chem 289, 14612-14623 (2014).
24. Sasaya, K., Sudo, H., Maeda, G., Kawashiri, S., Imai, K. Concomitant loss of p120-catenin and beta-catenin membrane expression and oral carcinoma progression with E-cadherin reduction. PLoS One 8, e69777 (2013).
25. Xu, X. et al. Aberrant Wnt1/beta-catenin expression is an independent poor prognostic marker of non-small cell lung cancer after surgery. J Thorac Oncol 6, 716-724 (2011).
26. Ito, T. et al. Survivin promotes cell proliferation in human hepatocellular carcinoma. Hepatology 31, 1080-1085 (2000).
27. Masaki, T. et al. Cyclins and cyclin-dependent kinases: comparative study of hepatocellular carcinoma versus cirrhosis. Hepatology 37, 534-543 (2003).
28. Ramachandran, I. et al. Wnt inhibitory factor 1 induces apoptosis and inhibits cervical cancer growth, invasion and angiogenesis in vivo. Oncogene 31, 2725-2737 (2012).
29. Inagawa, S. et al. Expression and prognostic roles of beta-catenin in hepatocellular carcinoma: correlation with tumor progression and postoperative survival. Clin Cancer Res 8, 450-456 (2002).
30. Endo, K., Ueda, T., Ueyama, J., Ohta, T.& Terada, T. Immunoreactive E-cadherin, alpha-catenin, beta-catenin, and gamma-catenin proteins in hepatocellular carcinoma: relationships with tumor grade, clinicopathologic parameters, and patients' survival. Hum Pathol 31, 558-565 (2000).
31. Schotte, D. et al. Identification of new microRNA genes and aberrant microRNA profiles in childhood acute lymphoblastic leukemia. Leukemia 23, 313-322 (2009).
32. Lovat, F., Valeri, N., Croce, C. M. MicroRNAs in the pathogenesis of cancer. Semin Oncol 38, 724-733 (2011).
33. Dyrskjot, L. et al. Genomic profiling of microRNAs in bladder cancer: miR-129 is associated with poor outcome and promotes cell death in vitro. Cancer Res 69, 4851-4860 (2009).
34. Slaby, O. et al. Altered expression of miR-21, miR-31, miR-143 and miR-145 is related to clinicopathologic features of colorectal cancer. Oncology 72, 397-402 (2007).
35. Zhao, G. et al. miR-148b functions as a tumor suppressor in pancreatic cancer by targeting AMPKalpha1. Mol Cancer Ther 12, 83-93 (2013).
36. Cuk, K. et al. Circulating microRNAs in plasma as early detection markers for breast cancer. Int J Cancer 132, 1602-1612 (2013).
37. Evan, G. I., Vousden, K. H. Proliferation, cell cycle and apoptosis in cancer. Nature 411, 342-348 (2001).
38. Mishra, P. J., Merlino, G. MicroRNA reexpression as differentiation therapy in cancer. J Clin Invest 119, 2119-2123 (2009).
39. Breckenridge, D. G., Xue, D. Regulation of mitochondrial membrane permeabilization by BCL-2 family proteins and caspases. Curr Opin Cell Biol 16, 647-52 (2004).
40. Benad, P., Rauner, M., Rachner, T. D., Hofbauer, L. C. The anti-progestin RU-486 inhibits viability of MCF-7 breast cancer cells by suppressing WNT1. Cancer Lett 312, 101-108 (2011).
41. Lee, T. H. et al. Enhanced nuclear factor-kappa B-associated Wnt-1 expression in hepatitis B-and C-related hepatocarcinogenesis: identification by functional proteomics. J Biomed Sci 13, 27-39 (2006).
42. Stanczak, A. et al. Prognostic significance of Wnt-1, beta-catenin and E-cadherin expression in advanced colorectal carcinoma. Pathol Oncol Res 17, 955-963 (2011).
43. Zhang, J. G. et al. Sirtuin 1 facilitates chemoresistance of pancreatic cancer cells by regulating adaptive response to chemotherapy-induced stress. Cancer Sci 105, 445-454 (2014).
44. Zhang, J. G. et al. Nicotinamide prohibits proliferation and enhances chemosensitivity of pancreatic cancer cells through deregulating SIRT1 and Ras/Akt pathways. Pancreatology 13, 140-146 (2013).
45. Zhao, G. et al. SIRT1 RNAi knockdown induces apoptosis and senescence, inhibits invasion and enhances chemosensitivity in pancreatic cancer cells. Gene Ther 18, 920-928 (2011).
46. Zhang, J. et al. microRNA-22, downregulated in hepatocellular carcinoma and correlated with prognosis, suppresses cell proliferation and tumourigenicity. Br J Cancer 103, 1215-1220 (2010).